CON:NYE-Concentra Group Holdings Parent, Inc. (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 21.11

Change

-0.38 (-1.77)%

Market Cap

USD 2.93B

Volume

0.54M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-25 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-0.18 (-0.05%)

USD 79.32B
THC Tenet Healthcare Corporation

-1.30 (-0.97%)

USD 12.13B
DVA DaVita HealthCare Partners Inc

-2.28 (-1.50%)

USD 11.92B
UHS Universal Health Services Inc

-0.35 (-0.19%)

USD 11.22B
EHC Encompass Health Corp

-0.36 (-0.36%)

USD 10.00B
CHE Chemed Corp

-6.66 (-1.09%)

USD 8.72B
ARDT Ardent Health Partners, Inc.

+0.04 (+0.30%)

USD 2.59B
NHC National HealthCare Corporatio..

-0.76 (-0.82%)

USD 1.90B
AGL agilon health Inc

-0.12 (-2.60%)

USD 1.67B
GRDN Guardian Pharmacy Services, In..

-0.96 (-4.55%)

USD 1.25B

ETFs Containing CON

EL4X:XETRA Deka DAXplus Maximum Divi.. 0.00 % 0.00 %

-0.38 (0.50%)

USD 0.29B
EXV5:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

-0.37 (0.50%)

USD 0.15B
CAPE:LSE Ossiam Shiller Barclays C.. 0.00 % 0.00 %

+2.60 (+0.50%)

USD 0.17B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.72% 67% D+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.72% 67% D+ 81% B-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 2.93B 71% C- 72% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.